Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
3927292 | European Urology | 2009 | 12 Pages |
Abstract
This study shows that, in bladder cancer, VEGFA status could be used as a prognostic factor at the individual level. VEGFA overexpression could guide a rationalized use of the costly antiangiogenic therapies which could therefore become part of the treatment options in bladder cancer.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Géraldine Pignot, Ivan Bieche, Sophie Vacher, Catherine Güet, Annick Vieillefond, Bernard Debré, Rosette Lidereau, Delphine Amsellem-Ouazana,